Full info on abstract publication for
AACR meeting in LA , should the company be participating:
Quote:
RELEASE DATE FOR REGULAR, CLINICAL TRIAL, AND LATE-BREAKING ABSTRACTS
Regular, clinical trial, and late-breaking abstract titles, poster numbers, and authors (no data) will be available on the AACR website on Monday, February 9, 2026, at 1 p.m. ET.
Regular abstracts (submitted for the December 1 deadline) selected for presentation during the conference (poster or oral) will be published as a freely available supplement in the AACR journal Cancer Immunology Research and in the conference app at 12 p.m. ET, on Wednesday, February 18, 2026—with the exception of abstracts selected for inclusion in the AACR press program.
Clinical trial and late-breaking abstracts (submitted for the January 20 deadline) will be publicly available to download through the conference app at 12 p.m. ET, on Wednesday, February 18, 2026—with the exception of abstracts selected for inclusion in the AACR press program.
Abstracts selected for inclusion in the AACR press program (regular, clinical trial, or late-breaking) will be publicly available to download through the conference app at the date and time that their press embargo lifts.
Abstracts will not be available before these dates.
Quote:
If we HAVE submitted an abstract to the Feb. meeting in LA, then we would hear on Monday.... the titles of the accepted abstracts are published at 1 pm Eastern on the 9th of Feb.